在患有外周动脉疾病的老年患者中,年龄与血栓凝血谱凝血概况的相关性
Adriana A Rodriguez Alvarez1, Isabella Ferlini Cieri1, Katherine L Morrow1
1Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA.
Journal of vascular surgery
|February 9, 2025
概括
在控制抗凝血时,年龄不会显著改变老年外周动脉疾病患者的血栓凝血图 (TEG) 凝血概况. TEG可以指导老年人的治疗.
科学领域:
- 血管外科 血管外科
- 血液学 血液学 血液学
- 老年医学 老年医学
背景情况:
- 周围动脉疾病 (PAD) 影响老年人群,需要抗凝管理.
- 血栓形成显微镜 (TEG) 评估凝血,但其在PAD中跨年龄组的实用性尚不清楚.
- 与年龄相关的凝血变化可能会影响PAD治疗结果.
研究的目的:
- 为了研究年龄对PAD的老年患者的血栓凝结谱 (TEG) 凝血概况的影响.
- 为了确定TEG参数是否在接受下肢再血管化的年轻 (65-74岁) 和年长 (75岁以上) 的老年患者之间有所不同.
- 测试假设TEG参数在控制抗凝血方案时在不同年龄组保持一致的假设.
主要方法:
- 这是一项对158名患者 (≥65岁) 的前性观察性研究,这些患者正在接受PAD的下肢再血管化.
- 患者按年龄分层 (65-74岁与75岁以上) 和抗凝血状态 (单抗血小板,双抗血小板,治疗性抗凝血,没有).
- 使用ANOVA和千平方/费舍尔精确测试,分析和比较年龄和抗凝血组之间的手术前TEG凝血概况.
主要成果:
- 通过抗凝血疗法分层的年龄组之间没有观察到TEG参数 (反应时间,最大幅度,溶解,角度,ADP聚合/抑制) 的显著差异 (所有P > .05).
- 在65-74岁和75岁以上的年龄组中,血栓形成率与65-74岁和75岁以上的年龄组相似 (21.1%对20.6%;P = .936).
- 在75岁以上的年龄组,死亡率明显高于65-74岁的年龄组 (20.6%对5.6%;P = .005).
结论:
- 通过TEG测量的客观凝血参数在老年PAD患者中与年龄没有显著差异,当抗凝血药物标准化时.
- 泰格 (TEG) 档案显示出在老年PAD人群中引导抗凝管理的潜力.
- 需要进一步的研究,以充分理解TEG在PAD老年患者凝血监测中的作用.
更多相关视频
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
27.3K
14:52Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
11.4K
相关概念视频
Assessment of the Cardiovascular System III: Palpation
176
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
176
Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
Disorders of Hemostasis
686
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
686
